Multiple endocrine neoplasia type 1 (MEN1), a rare tumor syndrome that is inherited in an
autosomal dominant pattern, is continuing to raise great interest for endocrinology …

The androgen receptor (AR) signaling axis drives all stages of prostate cancer, including the
lethal, drug-resistant form of the disease termed castration-resistant prostate cancer (CRPC) …

Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …

Abstract Background Multiple Endocrine Neoplasia type 1 (MEN1) is diagnosed when two
out of the three primary MEN1-associated endocrine tumors occur in a patient. Up to 10 …

Hypercalcitoninemia has frequently been reported as a marker for medullary thyroid
carcinoma. Currently, calcitonin measurements are mostly useful in the evaluation of tumor …

Multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disorder, is
characterised by the occurrence of pancreatic neuroendocrine tumours (P-NETs) in …

Despite its identification in 1997, the functions of the MEN1 gene—the main gene underlying
multiple endocrine neoplasia type 1 syndrome—are not yet fully understood. In addition …

Context: The natural course and survival of neuroendocrine tumors (NETs) of thymus (Th)
and lung in multiple endocrine neoplasia type 1 (MEN1) patients are still unknown …

Mutations of the multiple endocrine neoplasia type 1 (MEN1) gene lead to loss of function of
its protein product menin. In keeping with its tumor suppressor function in endocrine tissues …

MEN 1 is a rare hereditary cancer syndrome which manifests a variety of endocrine and non-
endocrine neoplasms and lesions. Growing knowledge of this condition in both its molecular …